Madison, WI – An agreement between UCLA and Roche (SIX: RO, ROG; OTCQX: RHHBY) will provide stem cell and cancer researchers with leading-edge technologies that will drive research capabilities and further the understanding of complex disease. The technologies, including the latest generation microarray systems from Roche NimbleGen, high-throughput screening instruments, genetic expression profilers and exome […]
SUNNYVALE, Calif. – Today, Molecular Devices, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced the launch of the GenePix® SL50 Slide Loader and GenePix® Pro 7.2 Software for an accelerated microarray workflow. Research needs change continually as science advances; Molecular Devices designed the SL50 Slide Loader as […]
POTOMAC FALLS, Va. – TessArae®, LLC, a privately held company, today announced that it has appointed Tom Richards as its new President. Dr. Richards has held faculty positions at Stanford University Medical Center and UCSF Medical Center, where he currently practices as an Assistant Clinical Professor in the Department of Emergency Medicine. Richards is a […]
SKOKIE, Ill. – NanoInk’s® Nano BioDiscovery™ Division announced today the launch of a new instrument system for nanoscale protein analysis and discovery. Coupling powerful array deposition techniques with the latest generation of fluorescent detection technologies, the NanoArray Assay System™ is a user friendly, affordable desktop unit that can quickly and costeffectively integrate into any proteomic […]
SANTA CLARA, Calif. – Affymetrix, Inc. (Nasdaq: AFFX) today announced that Dr. Frank Witney has been appointed president and chief executive officer, effective July 1, 2011. Dr. Witney joins Affymetrix with 30 years of experience in the life science research products and diagnostic and analytical instrument industry, having served in senior leadership positions at Dionex, […]
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced the release of its next generation targeted sequencing service. With an emphasis on flexibility, expert project design and advanced data analysis, the new offering takes advantage of OGT’s high-quality processes and in-house bioinformatics experience to provide […]
EL SEGUNDO, Calif. & SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ:AFFX) today announced a co-marketing agreement naming BioDiscovery, Inc. its preferred software provider for Affymetrix OncoScan™ FFPE Express Service data analysis. BioDiscovery, a leader in integrated software for high-throughput microarrays and other technologies, customized its Nexus Copy Number™ solution for Affymetrix to make the most […]
Crumlin, Antrim, United Kingdom – This new development brings the well established Biochip Array Technology to the point of care market, offering a higher level of information than ever achieved from a rapid drug screen – Randox.com. The Evidence MultiStat analyser is a fully automated, bench-top system with a state of the art touch screen […]
MADISON, Wis. – Gentel Biosciences, a leader in proteomics profiling tools, and Eprogen, jointly announce the publication of a new book chapter featuring Gentel’s native fractionation array technology. The article can be found in the latest edition of the Springer Protocols’ Methods and Protocols Series: Methods in Molecular Biology: Protein Microarray for Disease Analysis Methods […]
SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ:AFFX) today launched new Axiom(TM) myDesign(TM) Targeted Genotyping (TG) Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions. This latest advancement allows researchers to design custom arrays to genotype 1,500 to 2.6 million markers per sample and rapidly transition from […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
